These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

285 related items for PubMed ID: 12802021

  • 1. Hodgkin's disease--clinical trials and travails.
    DeVita VT.
    N Engl J Med; 2003 Jun 12; 348(24):2375-6. PubMed ID: 12802021
    [No Abstract] [Full Text] [Related]

  • 2. 14-day variant of the bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone regimen in advanced-stage Hodgkin's lymphoma: results of a pilot study of the German Hodgkin's Lymphoma Study Group.
    Sieber M, Bredenfeld H, Josting A, Reineke T, Rueffer U, Koch T, Naumann R, Boissevain F, Koch P, Worst P, Soekler M, Eich H, Müller-Hermelink HK, Franklin J, Paulus U, Wolf J, Engert A, Diehl V, German Hodgkin's Lymphoma Study Group.
    J Clin Oncol; 2003 May 01; 21(9):1734-9. PubMed ID: 12721249
    [Abstract] [Full Text] [Related]

  • 3. Standard and increased-dose BEACOPP chemotherapy compared with COPP-ABVD for advanced Hodgkin's disease.
    Diehl V, Franklin J, Pfreundschuh M, Lathan B, Paulus U, Hasenclever D, Tesch H, Herrmann R, Dörken B, Müller-Hermelink HK, Dühmke E, Loeffler M, German Hodgkin's Lymphoma Study Group.
    N Engl J Med; 2003 Jun 12; 348(24):2386-95. PubMed ID: 12802024
    [Abstract] [Full Text] [Related]

  • 4. Chemotherapy for Hodgkin's disease.
    Ekert H.
    N Engl J Med; 2003 Sep 18; 349(12):1186-7; author reply 1186-7. PubMed ID: 13679536
    [No Abstract] [Full Text] [Related]

  • 5. Will it be another 20 years before Hodgkin lymphoma patients benefit from BEACOPP therapy?
    Diehl V, Engert A.
    Nat Clin Pract Oncol; 2006 May 18; 3(5):227. PubMed ID: 16682982
    [No Abstract] [Full Text] [Related]

  • 6. MOPPEBVCAD chemotherapy with limited and conditioned radiotherapy in advanced Hodgkin's lymphoma: 10-year results, late toxicity, and second tumors.
    Gobbi PG, Broglia C, Levis A, La Sala A, Valentino F, Chisesi T, Sacchi S, Corbella F, Cavanna L, Iannitto E, Pavone V, Molica S, Corazza GR, Federico M.
    Clin Cancer Res; 2006 Jan 15; 12(2):529-35. PubMed ID: 16428496
    [Abstract] [Full Text] [Related]

  • 7. [Non-Hodgkin's lymphoma secondary to Hodgkin's disease treated with chemo- and radiotherapy. Report of a case].
    Gamboa Domínguez A, Pita Ramírez L, Hurtado Monroy R, Angeles-Angeles A.
    Rev Invest Clin; 1992 Jan 15; 44(3):393-8. PubMed ID: 1283228
    [Abstract] [Full Text] [Related]

  • 8. Radiotherapy for advanced Hodgkin's disease.
    Gupta T, Sanghavi V, Laskar S.
    N Engl J Med; 2003 Sep 18; 349(12):1187-8; author reply 1187-8. PubMed ID: 13679537
    [No Abstract] [Full Text] [Related]

  • 9. The use of combination chemotherapy in the treatment of early stage Hodgkin's disease.
    Longo DL, DeVita VT.
    Important Adv Oncol; 1992 Sep 18; ():155-65. PubMed ID: 1582671
    [No Abstract] [Full Text] [Related]

  • 10. [Controversy regarding the treatment of Hodgkin's disease].
    Balwierz W, Armata J.
    Pol Tyg Lek; 1989 Apr 03; 44(14):315-9. PubMed ID: 2482966
    [No Abstract] [Full Text] [Related]

  • 11. Recent advances in the therapy of Hodgkin's disease in elderly patients. The Piemonte Hodgkin's Disease Register (PHDR).
    Levis A.
    Hematol Oncol; 1993 Apr 03; 11 Suppl 1():78-84. PubMed ID: 7683625
    [No Abstract] [Full Text] [Related]

  • 12. Chemotherapy plus involved-field radiation in early-stage Hodgkin's disease.
    Fermé C, Eghbali H, Meerwaldt JH, Rieux C, Bosq J, Berger F, Girinsky T, Brice P, van't Veer MB, Walewski JA, Lederlin P, Tirelli U, Carde P, Van den Neste E, Gyan E, Monconduit M, Diviné M, Raemaekers JM, Salles G, Noordijk EM, Creemers GJ, Gabarre J, Hagenbeek A, Reman O, Blanc M, Thomas J, Vié B, Kluin-Nelemans JC, Viseu F, Baars JW, Poortmans P, Lugtenburg PJ, Carrie C, Jaubert J, Henry-Amar M, EORTC-GELA H8 Trial.
    N Engl J Med; 2007 Nov 08; 357(19):1916-27. PubMed ID: 17989384
    [Abstract] [Full Text] [Related]

  • 13. Lomustine, etoposide, vindesine, and dexamethasone (CEVD) in Hodgkin's lymphoma refractory to cyclophosphamide, vincristine, procarbazine, and prednisone (COPP) and doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD): a multicenter trial of the German Hodgkin Study Group.
    Pfreundschuh MG, Schoppe WD, Fuchs R, Pflüger KH, Loeffler M, Diehl V.
    Cancer Treat Rep; 1987 Dec 08; 71(12):1203-7. PubMed ID: 2446751
    [Abstract] [Full Text] [Related]

  • 14. Cardiopulmonary response to exercise in patients with different degrees of lung toxicity after radio-chemotherapy for Hodgkin's disease.
    Villani F, Busia A, Villani M, Laffranchi A, Viviani S, Bonfante V.
    Anticancer Res; 2009 Feb 08; 29(2):777-83. PubMed ID: 19331235
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Centralized radiation oncologic review of cross-sectional imaging of Hodgkin's disease leads to significant changes in required involved field-results of a quality assurance program of the German Hodgkin Study Group.
    Eich HT, Staar S, Gossmann A, Hansemann K, Skripnitchenko R, Kocher M, Semrau R, Engert A, Josting A, Franklin J, Krug B, Diehl V, Müller RP, German Hodgkin Study Group.
    Int J Radiat Oncol Biol Phys; 2004 Mar 15; 58(4):1121-7. PubMed ID: 15001253
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Transverse leukonychia following chemotherapy in a patient with Hodgkin's disease.
    Naumann R, Wozel G.
    Eur J Dermatol; 2000 Mar 15; 10(5):392-4. PubMed ID: 10882950
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Treating Hodgkin's disease: for whom the more means better?].
    Illés A.
    Magy Onkol; 2004 Mar 15; 48(2):157-61. PubMed ID: 15351812
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.